Company / Current Liabilities per Share
Terns Pharmaceuticals, Inc. Current Liabilities per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.20
FY2024
5-year range
$0.17 / $80.03
FY2020-FY2024
Trend
+17.4%
vs FY2023
Sector context
#189 of 208
Health Care
What the data says
Among 208 Health Care companies, Terns Pharmaceuticals, Inc. is in the top 9% for current liabilities per share. Current Liabilities per Share returned to growth in FY2024 after 3 years of decline, reaching $0.20.
Based on SEC 10-K filings.
0.20 in FY2024 with a 3-year CAGR of -13.1%.
Improved from $0.24 to $0.20 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -13.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 208This company $0.20 Sector average $26.71
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share increased 17.4% year-over-year.
- Ranks #189 out of 208 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.20 | +17.4% |
| FY2023 | $0.17 | -28.7% |
| FY2022 | $0.24 | -21.8% |
| FY2021 | $0.30 | -99.6% |
| FY2020 | $80.03 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026